Additionally, through enhancing hepatic antioxidant capacity and suppressing ROS-NF-κB-TNF-α inflammatory cascades, GA demonstrates therapeutic efficacy in MASLD rat models [183]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.